These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 17328129)

  • 1. Battling Alzheimer's disease, step by small step. Transforming growth factor (tgf-beta) and low brain oxygen levels provide more clues to AD.
    Duke Med Health News; 2007 Feb; 13(2):7. PubMed ID: 17328129
    [No Abstract]   [Full Text] [Related]  

  • 2. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
    Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
    Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease.
    Zetterberg H; Andreasen N; Blennow K
    Neurosci Lett; 2004 Sep; 367(2):194-6. PubMed ID: 15331151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease.
    Amtul Z; Wang L; Westaway D; Rozmahel RF
    Neuroscience; 2010 Aug; 169(2):781-6. PubMed ID: 20493928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.
    Wyss-Coray T; Lin C; Yan F; Yu GQ; Rohde M; McConlogue L; Masliah E; Mucke L
    Nat Med; 2001 May; 7(5):612-8. PubMed ID: 11329064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease.
    Wolf SA; Kronenberg G; Lehmann K; Blankenship A; Overall R; Staufenbiel M; Kempermann G
    Biol Psychiatry; 2006 Dec; 60(12):1314-23. PubMed ID: 16806094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta 1 is an organizer of responses to neurodegeneration.
    Finch CE; Laping NJ; Morgan TE; Nichols NR; Pasinetti GM
    J Cell Biochem; 1993 Dec; 53(4):314-22. PubMed ID: 8300749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
    Lee HG; Ueda M; Zhu X; Perry G; Smith MA
    J Neurosci Res; 2006 Dec; 84(8):1856-61. PubMed ID: 16998902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular delivery of a single chain antibody gene prevents brain Aβ deposition and cognitive impairment in a mouse model of Alzheimer's disease.
    Wang YJ; Gao CY; Yang M; Liu XH; Sun Y; Pollard A; Dong XY; Wu XB; Zhong JH; Zhou HD; Zhou XF
    Brain Behav Immun; 2010 Nov; 24(8):1281-93. PubMed ID: 20595065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 is increased in a transgenic mouse model of familial Alzheimer's disease and causes neuronal apoptosis.
    Salins P; He Y; Olson K; Glazner G; Kashour T; Amara F
    Neurosci Lett; 2008 Jan; 430(1):81-6. PubMed ID: 18063474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
    Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease.
    Hutter-Paier B; Huttunen HJ; Puglielli L; Eckman CB; Kim DY; Hofmeister A; Moir RD; Domnitz SB; Frosch MP; Windisch M; Kovacs DM
    Neuron; 2004 Oct; 44(2):227-38. PubMed ID: 15473963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities.
    Gaertner RF; Wyss-Coray T; Von Euw D; Lesné S; Vivien D; Lacombe P
    Neurobiol Dis; 2005; 19(1-2):38-46. PubMed ID: 15837559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
    Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
    Wyss-Coray T
    J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model.
    Julien C; Tremblay C; Phivilay A; Berthiaume L; Emond V; Julien P; Calon F
    Neurobiol Aging; 2010 Sep; 31(9):1516-31. PubMed ID: 18926603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels.
    Pacheco-Quinto J; Rodriguez de Turco EB; DeRosa S; Howard A; Cruz-Sanchez F; Sambamurti K; Refolo L; Petanceska S; Pappolla MA
    Neurobiol Dis; 2006 Jun; 22(3):651-6. PubMed ID: 16516482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.
    Janus C; Pearson J; McLaurin J; Mathews PM; Jiang Y; Schmidt SD; Chishti MA; Horne P; Heslin D; French J; Mount HT; Nixon RA; Mercken M; Bergeron C; Fraser PE; St George-Hyslop P; Westaway D
    Nature; 2000 Dec 21-28; 408(6815):979-82. PubMed ID: 11140685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.